198
Results-
Home PageCreated on : - Last modified on :
-
NewsBLUE MARCH - Colorectal Cancer Awareness MonthCreated on : - Last modified on :
-
NewsPierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmeticsCreated on : - Last modified on :From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories’ leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. Toulouse, February 19, 2026 – Avène, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign, has announced a major breakthrough in the field of clinical studies in dermo-cosmetics.
-
Business DevelopmentCreated on : - Last modified on :
Our Business Development & Licensing teams are made up of professionals capable of understanding all stages of pharmaceutical development and are available to discuss your innovative projects.
-
Press ReleaseInternational Rare Disease Day – February 28, 2026Created on : - Last modified on :Pierre Fabre Laboratories committed to fighting rare diseases through innovative therapies and game-changing partnershipsIn the European Union, a rare disease is defined as affecting fewer than 5 people per 10,000, and about 80% of these diseases are of genetic origin.1 Despite their individual rarity, it is estimated that approximately 1 in 17 people will develop a rare disease at some point in their lifetime2.
-
NewsGustave Roussy Prize: Pierre Fabre, founding sponsor of the research‑focused award, honors a leading researcherCreated on : - Last modified on :On the occasion of World Cancer Day, the 2026 Gustave Roussy Prize was awarded to Prof. Luis Diaz Jr., an international figure in oncology whose work has transformed the care of thousands of patients worldwide. As the founding patron of the Prize, Pierre Fabre salutes a major scientific breakthrough and reaffirms its commitment alongside the research teams shaping the future of precision medicine.
-
NewsBreast Cancer Awareness MonthCreated on : - Last modified on :Breast cancer is the most commonly diagnosed cancer in women1, with more than 2 million new cases reported each year worldwide.2 It accounts for 1 in 4 annual cancer cases globally.1Breast cancer is the leading cause of death by cancer in women.2 Although more frequent after age 50, breast cancer can also occur in younger patients.1 Also, even though most breast cancer cases occur in women, it can also occur in men (around 1% of cases). 3
-
NewsEmmanuelle HOCQUARD de KERLEAU appointed Chief Impact and Reputation OfficerCreated on : - Last modified on :Castres, January 29, 2026 - Emmanuelle HOCQUARD de KERLEAU has been appointed Chief Impact and Reputation Officer at Pierre Fabre Laboratories, which owns a portfolio of international dermo-cosmetic brands including
-
Our CommitmentsCreated on : - Last modified on :
-
Our Sustainable Development PolicyCreated on : - Last modified on :
Being environmentally-friendly, reducing our carbon footprint and supporting our communities, while delivering safe and effective products
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.